FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation - Brave, M; Farrell, A; Ching, Lin S (Oncology, 2010)
et al.